Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy.

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Abstract Text:

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer biology & therapy

VOLUME: 7

Page Numbers: 120-1

Journal Abbreviation: Cancer Biol. Ther.

ISSN: 1555-8576

DAY: 11

MONTH: 02

YEAR: 2008

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101137842

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy.

AFFILIATION: The Wistar Institute and Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Biol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy Related Publications

• Adenovirus infection enhances killing of melanoma cells by a mitotoxin.
• An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
• CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
• Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
• Dynamics of cell interactions and communications during melanoma development.
• Endothelial cells as targets for tumor therapy.
• Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
• Learning the ABCs of Melanoma-Initiating Cells.
• Life isn't flat: taking cancer biology to the next dimension.
• Melanoma and the tumor microenvironment.
• Melanoma stem cells: the dark seed of melanoma.
• Old disease, new culprit: tumor stem cells in cancer.
• Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
• Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy.
• Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
• Targeting the stromal fibroblasts: a novel approach to melanoma therapy.
• The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis.
• The many faces of Notch signaling in skin-derived cells.
• Unraveling the mysteries of IGF-1 signaling in melanoma.
• [1st successful immunization of pancreas and colorectal carcinoma patients with CO17-1A-vaccine]
• [Not Available.]
• [POSTOPERATIVE EFFECTS OF CESAREAN SECTION.]
• [Stability of Teschen, HCC, ND and vaccinia viruses against 5 disinfectants]